期刊文献+

白癜风的外用药治疗研究进展

Research progress in external drug treatment of vitiligo
下载PDF
导出
摘要 目的总结近年来治疗白癜风的外用药的研究进展。方法通过查阅近年来国内外公开发表的文献,归纳总结治疗白癜风的外用药物的作用机制、治疗疗效及不良反应。结果局部皮质类固醇药物、局部钙调神经磷酸酶抑制剂、维生素D类衍生物、5-氟尿嘧啶、前列腺素F2α衍生物、碱性成纤维细胞生长因子衍生肽、Janus激酶(Janus kinase,JAK)抑制剂外用治疗白癜风均有效,而假过氧化氢酶/超氧化物歧化酶(pseudo catalase/superoxide dismutase,PSD)、甲氨蝶呤外用治疗白癜风疗效不确切。结论通过对治疗白癜风的外用药物的综述,对将来新的治疗方式和新药物的研发提供依据。 Objective To summarize the research progress in external drug treatment of vitiligo in recent years.Methods By reviewing the literature published at home and abroad in recent years,the mechanism of action,therapeutic efficacy and adverse reactions of external agents for the treatment of vitiligo were summarized.Results Topical corticosteroids,topical calcineurin inhibitors,vitamin D derivatives,5-fluorouracil,prostaglandin F2αderivatives,basic fibroblast growth factor derived peptide,and Janus kinase(JAK)inhibitors were effective in the treatment of vitiligo,while the efficacy of pseudo-catalase/superoxide dismutase(PSD)and methotrexate in the treatment of vitiligo was not sure.Conclusion By reviewing the external agents for the treatment of vitiligo,it provides guidance for the development of new treatment methods and new drugs in the future.
作者 雷洁 蒋志欣 LEI Jie;JIANG Zhixin(Department of Dermatology,the First People’s Hospital of Longquanyi District of Chengdu,Chengdu 610100,China)
出处 《西北药学杂志》 2024年第1期228-233,共6页 Northwest Pharmaceutical Journal
基金 四川省(青年创新)科研课题(编号:Q20035)。
关键词 白癜风 外用药 作用机制 vitiligo external use drugs mechanism
  • 相关文献

参考文献13

二级参考文献67

  • 1张卉,朱海琴,范卫新.拉坦前列素对人毛乳头细胞增殖及分泌血管内皮细胞生长因子的影响[J].临床皮肤科杂志,2006,35(5):283-285. 被引量:7
  • 2Ewa Marcinkowska.A run for a membrane vitamin D receptor[J].Biol Signals Recept,2001,10(6):341-349.
  • 3Atsuko TG,Satyanarayana R,Tadashi K,et al.Nuclear factor of activated T cells (NFAT) as a molecular target for 1a,25-Dihydroxyvitamin D3-mediated effects[J].J Immunol,1998,160(1):209-218.
  • 4Penna G,Adorini L.1a,25-dihydroxyvitamin D3 inhibits differentiation,maturation,activation,and survival of dendritic cells leading to impaired alloreactive T cell activation[J].J Immuno,2000,164(5):2405-2411.
  • 5Canning OM,Grotenhuis K,Wit H,et al.1a,25-dihydroxyvitaming D3 hampers the maturation of fully active immature dendritic cells from monocytes[J].Eur J Endocrinol,2001,145(3):351-357.
  • 6Adorini L,Penna G,Giarratana N,et al.Dendritic cells as key targets for immunomodulation by vitamin D receptor ligands[J].J Steroid Bio Mole Bio,2004,89-90(1-5):437-441.
  • 7Teodora P,Staeva V,Leonard PF.1,25-Dihydroxyvitamin D3 inhibits IFN-γ and IL-4 levels during in vitro polarization of primary murine CD4+T cells[J].J Immunol,2002,168(3):1181-1189.
  • 8Marco C,Cinzia F,Danilo DB,et al.Negative regulation of CD95 ligand gene expression by vitamin D3 in T lymphocytes[J].J Immunol,2002,168(3):1154-1166.
  • 9Regu SG,Mara C,Susana A,et al.Regulatory T cells induced by 1,25-Dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance1[J].J Immunol,2001,167(4):1945-1953.
  • 10Luciano A.Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases[J].Int Immunopharmacol,2002,2(7):1017-1028.

共引文献114

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部